About Parkinson's Disease source: http://www.parkinsonsinfo.com/.
Adler, Charles H. "COMT Inhibitors: Novel Treatments for Parkinson's Disease." CME Reviews.
Agid, Yves. "Parkinson's Disease: Pathophysiology," The Lancet, June 1, 1991, Vol. 337, No. 8573; pp. 1321-1325.Ben-Shlomo, Y.; Churchyard, A.; Head, J.; Hurwitz, B.; Overstall, P.; Ockleford, J.; Lees, A.J., "Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegeline treatment in patients with early, mild Parkinson's disease," British Medical Journal 316 (1998): 1191-1197.
Bernstein, Ken. "The Parkinson's Web." Jun. 1, 1997. source: http://lansbury.bwh.harvard.edu/parkinson_disease.htm
Beyer, Peter L.; Palarino, Mary Y.; Michalek, Debra; Busenbark, Karen; Koller, William C. Weight change and body composition in patients with Parkinson's disease. Journal of the American Dietetic Association. Sept. 1995; 95:979-983.Bilang-Bleuel, A.; Revah, F.; Colin, P.; Locquet, I.; Robert, J.; Mallet, J.; Horellou, P., "Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease," Proceedings of the National Academy of Sciences of the United States 94 (Aug 1997): 8818-8824.
Black, Ira B., Information in the Brain: A Molecular Perspective. Cambridge, MA: MIT Press, 1991, pp. 68-72.
Carlson, Neil Physiology of Behavior, 6th ed. Needham Heights, MA: Allyn and Bacon, 1998, pp.234-236, 242-245.
Choi-Lundberg, Derek L.; Lin, Qing; Chang, Yung-Nien; Chiang, Yawen L.; Hay, Carl M.; Mohajeri, Hasan; Davidson, Beverly L.; and Bohn, Martha C. "Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy." Science, Feb. 7, 1997, Vol. 275, pp.838-841.
Cummings, Jeffrey, L. "Managing Psychosis in Patients with Parkinson's Disease" New England Journal of Medicine, Mar. 11, 1999, Vol. 340, No. 10, pp. 801-3.
Cummings, Jeffrey L. Understanding Parkinson's Disease. JAMA, The Journal of the American Medical Association. Jan. 27, 1999; 281:376-378."Dopamine agonist may improve Parkinsons, reduce L-dopa dosing," Geriatrics 53 (1998): 14.
Duvoisin, R.; and Sage, J. Genetics: A family condition.
Eccles, John, C. The Understanding of the Brain, 2nd ed. New York: McGraw-Hill Book Company, 1997, 134-137.
Ellgring, H.; Seiler, S.; Perleth B.; Frings, W.; Gasser, T.; and Oertel, W. "Psychosocial Aspects of Parkinson's Disease." Neurology, Dec. 1993, Vol. 43 (Suppl. 6), pp. 41-46.
Finger, Stanley Origins of Neuroscience Oxford University Press, Inc., New York, New York, 1994.
Gash, Don M. "Protein Cure for Parkinson's?". Science News, April 6, 1996, Vol. 149, No. 2, pp.221.
Gilbert, Michele;Counsell, Colleen;Snively, Christie. Pallidotomy: a surgical intervention for control of Parkinson's disease. Journal of Neuroscience Nursing. August 1996; 28:215-218.Golbe L.I., "Deprenyl as symptomatic therapy in Parkinson's disease," Clinical Neuropharmacology 11 (1988): 387-400.Gregory, T., "Augmentation therapies for advanced Parkinson's disease," Patient Care 33 (1999): 108.
Henkel, John. "Parkinson's Disease: New Treatments Slow Onslaught of Symptoms." FDA Consumer Magazine. Jul.-Aug. 1998. source: http://www.fda.gov/fdac/features/1998/498_pd.htmlTamara Hershey, Kevin J. Black, Mikula K. Stambuk, Juanita L. Carl, Lori A. McGee-Minnich, Joel S. Perlmutter, "Altered thalamic response to levodopa in Parkinson's patients with dopa-induced dyskinesias," Proceedings of the National Academy of Sciences of the United States 95 (1998): 12016-12022.
Krauss, Joachim K.; Jankovic, Joseph. Surgical treatment of Parkinson's disease. American Family Physician; 54:1621-1630.
Lieberman, Abraham "An Integrated Approach to Patient Management in Parkinson's Disease" Neurologic Clinincs, May 1992, Vol. 10, No. 2, pp. 553-564.
Lin, Leu-Fen H. "Glial Cell Line-Derived Neurotrophic Factor (GDNF): A Comprehensive Review." Promega. Dec. 28, 1998."Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease," The New England Journal of Medicine 340 (1999): 757-764. Mack, James E., "New strategies in parkinson's disease" Drug Topics 140 (1996): 72-82.
Mayberg, Helen S.; Solomon, Diane H. "Depression in Parkinson's Disease: A biochemical and Organic Viewpoint" Behavioral Neurology of Movement Disorders, 1995, Vol. 65, pp. 49-57.
McGeer, Edith G. Parkinson's Disease in Encyclopedia of Human Biology. 1997; 6:535-542.
Marsden, C. D., "Parkinson's Disease" The Lancet, April 21, 1990, Vol.335, No. 8695; pp. 948-953.
Mohr, Bettina; Muller, Viktor; Mattes, Regina; Rosin, Regina; Federmann, Barbara; Strehl, Ute; Pulvermuller, Friedemann; Muller, Friedemann; Lutzenberger, Werner; Birbaumer, Niels. "Behavioral Treatment of Parkinson's Disease Leads to Improvement of Motor Skills and to Tremor Reduction." Behavior Therapy, Spring 1996, Vol. 27, pp. 235-255.
Murray, John B. "Depression in Parkinson's Disease" The Journal of Psychology, 1996, Vol. 130, No. 6, pp. 659-667.
" Parkinson's Disease." We Move. Apr. 12, 1999. source: http://www.wemove.org
Parkinson's Disease: A guide for patient and family.Lippincott-Raven, Philadelphia, 1995.Parkinson Study Group, "Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease," New England Journal of Medicine 328 (1993): 176-83.
Polymeropoulos, Michael H., et al. Laboratory of Genetic Disease Research, National Center for Human Genome Research. National Institutes of Health, Bethesda. 1996:1197-1199.
Quinn, Niall. "Parkinsonism-recognition and differential diagnosis," British Medical Journal. Feb. 18, 1995; 310:447-452.
Quinn, Niall; Bhatia, Kailash. "Functional neurosurgery for Parkinson's Disease," British Medical Journal. April 25, 1998; 316:1259-1261.
R. and D. Systems. "GDNF Does More than Expected." The Cytokine Bulletin. Spring, 1995.Schapira, A. H. V., "Parkinson's disease. (Science, Medicine, and the Future)," British Medical Journal 318 (1999): 311.Seaton T.A., Cooper J.M., Schapira A.H.V., "Free radical scavengers protect dopaminergic cell lines from apoptosis induced by mitochondrial complex I inhibitors," Brain Research 777 (1997): 110-118.
Stein, Murray B.; Heuser, Isabella J.; Juncos, Jorge L.; and Uhde, Thomas W. "Anxiety Disorders in Patients with Parkinson's Disease" American Journal of Psychiatry, February 1990, Volume 147, No. 2, pp. 217-220.
Tanner, C.M.; Ottman, R.; Goldman, S.M.; Ellenberg, J.: Chan, P.: Mayeux, R.: and Langston, J.W. "Parkinson Disease in Twins." Journal of the American Medical Association, Jan. 27, 1999, Vol. 281, No. 4, pp. 341-346.Thomas, P., "Parkinson's Disease: pallidotomy the second time around," Harvard Health Letter 21 (Sep. 1996): 4-7.
Weghorst, Suzanne. "Augmented Reality and Parkinson's Disease." Communications of the ACM. Aug. 1997, Vol. 40, No. 8, pp. 47-48.Back to Home Page